Table 1 Characteristics of unexplained paediatric hepatitis cases and related specimens

From: Genomic investigations of unexplained acute hepatitis in children

Case ID

Sex

Liver transplant

Sender

Specimen 1

ID 1

Specimen 2

ID 2

Specimen 3

ID 3

1

M

Yes

BCH

Liver

JBL1

    

2

M

Yes

BCH, PHW

Liver

JBL4

NPA

JBN1

  

3

F

Yes

BCH

Liver

JBL3

    

4

M

Yes

BCH, UKHSA

Liver

JBL2

Blood

JBB25

  

5

F

Yes

BCH

Liver

JBL5

    

6

F

No

UKHSA

Blood

JBB9

Blood

JBB14

Blood

JBB16

7

F

No

UKHSA

Blood

JBB11

Blood

JBB10

  

8

F

No

UKHSA

Serum

JBPL1

Blood

JBB13

  

9

M

No

UKHSA

Blood

JBB1

    

10

M

No

UKHSA

Blood

JBB15

    

11

NA

No

GRI

Blood

JBB2

    

12

M

No

UKHSA

Blood

JBB12

    

13

NA

No

GRI

Blood

JBB7

    

14

NA

No

GRI

Blood

JBB8

    

15

NA

No

GRI

Blood

JBB4

Blood

JBB3

  

16

NA

No

GRI

Blood

JBB5

    

17

F

No

UKHSA

Throat swab

JBB18

Stool

JBB17

  

18

F

No

UKHSA

Blood

JBB19

    

19

F

No

UKHSA

Blood

JBB20

Blood

JBB23

  

20

M

No

UKHSA

Blood

JBB21

    

21

NA

No

PHW

NPA

JBB26

    

22

NA

No

GRI

Stool

JBB27

    

23

NA

No

GRI

Throat swab

JBB28

Stool

JBB30

  

24

NA

No

GRI

Stool

JBB29

    

25

NA

No

NHSL

Blood

JBB31

    

26

NA

No

NHSL

Stool

JBB32

    

27

F

No

UKHSA

Blood

JBB24

    

28

M

Yes

KCH

Liver

JBL6

    

29

F

Yes

KCH

Liver

JBL7

Liver

JBL8

  

30

F

No

KCH

Liver

JBL9

    

31

F

Yes

KCH

Liver

JBL10

    

32

M

Yes

KCH

Liver

JBL11

Serum

JBB34

  

33

F

Yes

KCH

Liver

JBL12

    

34

M

Yes

KCH

Liver

JBL13

Serum

JBB36

  

35

F

No

KCH

Liver

JBL14

Serum

JBB35

  

36

M

Yes

KCH

Liver

JBL15

Serum

JBB37

  

37

F

No

KCH

Serum

JBB38

    

38

M

No

KCH

Serum

JBB39

    
  1. The median age for the cases is 3 years of age (age range: 1–9 years of age). Case 10 was 9 years of age. All other cases were 7 years of age or younger.
  2. Cases 1–5 underwent liver transplant and had metagenomic next-generation sequencing (mNGS), PCR and viral whole-genome sequencing (WGS) of their specimens. Cases 28, 29, 31–34 and 36 also underwent liver transplant and had PCR for all three viruses under investigation. BCH sent the liver explant for case 2, PHW the NPA. BCH sent the liver for case 4, UKHSA the blood.
  3. Cases 6–27, 30, 35, 37 and 38 did not receive a liver transplant. Cases 30 and 35 had liver biopsies. Cases 6–10 had metagenomic next-generation sequencing, PCR and viral WGS on their samples. Cases 11–22 had PCR for one to two of the viruses under investigation and viral WGS of positive PCRs. Cases 23–27 only had HAdV WGS on their samples and there was no residual material for further testing. Cases 31, 36, 38 and 39 had PCR for all three viruses under investigation.
  4. BCH, Birmingham Children’s Hospital; F, female; GRI, Glasgow Royal Infirmary; KCH, King’s College Hospital; M, male; NA, not applicable; NHSL, NHS Lothian; NPA, nasopharygeal aspirate; PHW, Public Health Wales.